featured
Fixed-Dose Coadministration of Pramlintide Plus Regular Insulin Shows Promise for Postprandial Hyperglycemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study
Diabetes Care 2018 Sep 13;[EPub Ahead of Print], MC Riddle, R Nahra, J Han, J Castle, K Hanavan, M Hompesch, D Huffman, P Strange, P ÖhmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.